Organization | Yazd Research & Clinical Center for Infertility

Yazd Research & Clinical Center for Infertility Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Yazd Iran (Islamic Republic of) (1989)

Organization Overview

First Clinical Trial

2008

NCT00823602

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2009

Timeline

NOW

Now

Alternative names

Yazd Research and Clinical Centre for Infertility

Active Ingredients

Drugs in Phase 4 Trials (3)

buserelin (receptal) (3 trials)

clomifene (clomid) (1 trial)

heparin (liquaemin) (1 trial)

Drugs in Phase 3 Trials (1)

ganirelix (2 trials)

Drugs in Phase 2 Trials (5)

desogestrel (Mercilon) (1 trial)

ethinyl estradiol (Estinyl) (1 trial)

follitropin alfa (Gonal-F) (1 trial)

letrozole (femara) (1 trial)

urofollitropin (Metrodin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Infertility (Phase 3)

Thrombophilia (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 9